4//SEC Filing
Landon Kristen 4
Accession 0001213900-25-076984
CIK 0001946563other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 9:24 PM ET
Size
6.1 KB
Accession
0001213900-25-076984
Insider Transaction Report
Form 4
Landon Kristen
Chief Operating Officer
Transactions
- Award
Stock Options (Right to Buy)
2024-09-26+4,167→ 4,167 totalExercise: $6.85Exp: 2034-09-26→ Common Stock (4,167 underlying)
Footnotes (3)
- [F1]The options were granted pursuant to the 60 Degrees Pharmaceuticals, Inc. 2022 Equity Incentive Plan. The options shall vest and become exercisable in five equal tranches on the last date of each fiscal year, with the first vesting date being December 31, 2024. The options have a maximum term of 10 years from the date of grant.
- [F2]This Form 4 is being filed late due to an inadvertent administrative error.
- [F3]All information has been retroactively adjusted to reflect the 1-for-5 reverse stock split effected by the Issuer on February 24, 2025.
Documents
Issuer
60 DEGREES PHARMACEUTICALS, INC.
CIK 0001946563
Entity typeother
Related Parties
1- filerCIK 0002053910
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 9:24 PM ET
- Size
- 6.1 KB